Private MD News - Hormones and Metabolism

Home | News | Hormones and Metabolism

View Articles by Date

Year: 2013 2012 2011 2010 2009

Month: JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC

Following research conducted by the Oregon Health and Science University in Portland, a new approach to treating misfolded proteins could lead to cures for a wide range of diseases. Lab tests carried out on mice may bring about revolutionary changes in treatment for ailments such as cystic fibrosis and cataracts.

The study, published in the Proceedings of the National Academy of Sciences, was led by Michael Conn, Ph.D., former professor of physiology and pharmacology at OHSU. His team looked to discover a new method to fix misfolded proteins and restore them to make cells function correctly. Using male mice incapable of fathering offspring, the researchers were able to cure the mice and perfect the process through lab testing. They believe the same treatment could be used on humans.

"The opportunity here is going to be enormous because so many human diseases are caused by misfolded proteins. The ability of these drugs - called 'pharmacoperones' - to rescue misfolded proteins and return them to normalcy could someday be an underlying cure to a number of diseases," affirmed Conn.

Previously, scientists believed inactive proteins were naturally non functional. But Conn and his team of researchers showed that when the proteins were misfolded, their purpose was rerouted and caused a malfunction. The pharmacoperones are used to correct the routing problem and correctly fold proteins for functioning.

"We expect that these studies will change the way drug companies look for drugs, since current screening procedures would have missed many useful pharmacoperone drugs."

According to Conn, the next step in the process will be clinical trials on humans.

What are misfolded proteins?... Full Story